Anvajo raises 17.7 million euros
Marius Ochs
| 20.10.2022
The healthtech from Dresden thus successfully closes its Series A round.
In its Series A financing round, the Dresden-based health tech start-up receives a total of 17.7 million euros. Investors include Medice Arzneimittel, Elber Beteiligungen, and Think.Health from Germany, as well as Johnsoville Ventures from the US. The existing investor, Die BrückenköpfeX, also gave additional money. The new capital is intended to accelerate the company's launch, particularly in human medical markets.
Founder Stefan Fraedrich wanted to use Anvajo in 2016 to build a platform technology for the prevention, monitoring and screening of chronic kidney disease. Simply, fewer devices should be needed for the diagnoses. He founded his startup as a spin-off from the Technical University of Dresden. According to Anvajo, the fluid analysis technology is already being used in two devices in veterinary medicine and science. In rural areas in particular, the analysis method should provide relief in the future.
Newsletter
Startups, stories and stats from the German startup ecosystem straight to your inbox. Subscribe with 2 clicks. Noice.
LinkedIn ConnectTake care, give care
Did this news inform or entertain you? Then we would be happy if you tell your network about it.
Share on Linkedin Share on Facebook Share on XingRelated companies
Investor
Fürstenfeldbruck
Startup
2016
Dresden
FYI: English edition available
Hello my friend, have you been stranded on the German edition of Startbase? At least your browser tells us, that you do not speak German - so maybe you would like to switch to the English edition instead?
FYI: Deutsche Edition verfügbar
Hallo mein Freund, du befindest dich auf der Englischen Edition der Startbase und laut deinem Browser sprichst du eigentlich auch Deutsch. Magst du die Sprache wechseln?
